ASMI wants switch plan
This article was originally published in OTC Bulletin & The Rose Sheet
Executive Summary
Australia’s government should adopt a “progressive switch agenda” to help increase significantly the number of medicines available OTC in the country, according to the Australian Self Medication Industry (ASMI).
You may also be interested in...
Protect IP To Encourage Switching In Australia, Urges ASMI
The Australian Self Medication Industry (ASMI) is calling for IP protection for successful prescription-to-OTC reclassification applications to encourage switching in Australia.
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.